22nd Century Group, Inc.


9530 Main StClarenceNew York14031United States View Map


$8.5 Million



SIC Codes:

2833, 2836

NAICS Codes:

325412, 325411


(716) 270-1523


(716) 877-3064


22nd Century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine and other nicotinic alkaloids (e.g., nornicotine, anatabine and anabasine) in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. 22nd Century owns or is the exclusive licensee of 116 issued patents in 78 countries plus an additional 42 pending patent applications. Goodrich Tobacco Company, LLC and Hercules Pharmaceuticals, LLC are wholly-owned subsidiaries of 22nd Century. Goodrich Tobacco is focused on commercial tobacco products and potentially less harmful cigarettes. Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development.

Read More

Recently Updated profiles at this company

Vice President of Business Development

President and Chief Executive Officer

Chief Financial Officer

Vice President of Plant Biotechnology

Vice President, General Counsel and Secretary

Vice President Research and Development

Vice President of Regulatory Affairs

Director of Marketing and Special Projects

Investor Relations Coordinator

Operations Manager

Browse ZoomInfo’s Directories